Wednesday, August 26, 2026
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· January 9, 2026

74% of the $317 Billion Portfolio Warren Buffett Left for Berkshire Hathaway's New CEO, Greg Abel, Is Invested in These 8 Unstoppable Stocks in 2026

View original at nasdaq.com
74% of the $317 Billion Portfolio Warren Buffett Left for Berkshire Hathaway's New CEO, Greg Abel, Is Invested in These 8 Unstoppable Stocks in 2026 Key Points Warren Buffett has officially retired from the CEO role at Berkshire Hathaway…
Opening lines of the source · short snapshot — read the full document at the original

What we drew from this source

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Lower interest rates are expected to weigh on Bank of America's net interest income in the coming quarters

    80% confidence
  • The Motley Fool analyst team identified 10 best stocks to buy now, and Apple wasn't one of them

    80% confidence
  • Greg Abel has vowed to run Berkshire Hathaway similarly to his predecessor, as a long-term-minded, value-focused investor

    80% confidence
  • Chevron forecasts $10 billion to $20 billion in annual share buybacks through 2030

    80% confidence

Data points we hold from this source

Apple Podcasts · portfolio percentage20.1 percent
Apple Podcasts · shares retired44 percent
Apple Podcasts · buyback spending816 billion_USD
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Leadership Exodus Rattles Investor Confidence Amid Capex Boom
High-profile departures at top AI labs — Brad Lightcap's exit from OpenAI and an unnamed researcher's departure from Alphabet/Google that triggered a share-price drop — are surfacing talent retention as a market risk factor even as hyperscalers pour record capital into AI infrastructure. The reaction shows investors treating key-person risk at frontier AI labs as material to valuation, a new fragility layered onto an otherwise bullish AI-driven capex cycle.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Broadcom Inc.
Both facts report EPS for Broadcom Inc. for the same fiscal period (Q1 2026) observed on the same date (2026-02-01). However, they report conflicting values: 1.5 USD per share vs 2.05 USD per share. This is a 37% difference for the identical metric and time period, not a value change over time.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,978
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,978 facts checked against source5,251 source documents archived
Query this data → isubstrate.com
74% of the $317 Billion Portfolio Warren Buffett Left for Berkshire Hathaway's New CEO, Greg Abel, Is Invested in These 8 Unstoppable Stocks in 2026 — Source | Via News | ViaNews Market